cancer doctors

Kidney Cancer Metastasis

Question: Herbal Cancer Cure ?? Could it be true ?? Please help, your suggestion matters to me now !? My dad's been diagnosed with renal carcicoma (cancer in the kidney) with lung metastasis (cancer cells from the kidney spreading to the lungs) We were shattered and we are doing everything to help him and I came across this strange website. I really do not trust it, but I would love to have your opinions and help and whatever you could tell me. Please please do reply or write in and tell me if this is genuine. Thank you. the website is - www.tianxian.com

Answer: I'm so sorry to hear about your dad. You are right not to trust this website; please be wary of websites about miracle cancer cures. They are targetting people exactly like you, people who are devastated, desperate and vulnerable. They're after your cash. 'Alternative' in this context is just another word for 'unproven'. If this product had been thoroughly tested and proven to be effective against cancer, we would know about it. Be wary of unsubstantiated testimonials - you have no way of knowing if the person ever had cancer, much less that they were cured. Wherever there's cancer there's an unscrupulous charlatan eager to part patients and their families from their cash for ineffective and sometimes dangerous 'cures'. My best wishes to your dad, and to you


Kidney Cancer Metastasis News

Kidney Ca Drugs Worked Better Inside Trials

MedPage Today
Explain that metastatic kidney cancer patients deemed ineligible for targeted therapy clinical trials, but who still receive the trial treatment protocol in clinical practice, face a higher mortality risk. Point out that progression-free survival on ...
 

Cabozantinib Shows Encouraging Activity in Advanced Renal Cell Carcinoma

Drug Discovery & Development
Exelixis Inc. reported preliminary data from pre-treated patients with metastatic refractory renal cell carcinoma (RCC) participating in an ongoing Phase 1b trial of cabozantinib, a potent, dual inhibitor of MET and VEGFR2 that provides coordinated ...
 

Cabozantinib Shows Encouraging Activity in Heavily Pretreated Patients With ...

EON: Enhanced Online News (press release)
Toni K. Choueiri, MD, Director of the Kidney Cancer Center at the Dana-Farber Cancer Institute, will present the data (Abstract #364) in a poster session at the 2012 Genitourinary Cancers Symposium at 6:45 am PST tomorrow in San Francisco.
 

Kuwait Times

FDA Approves Pfizer Kidney Cancer Drug Inlyta
Wall Street Journal
 

Early data show kidney cancer response to Exelixis' 'cabo'

Bizjournals.com (blog)
Exelixis Inc. 's experimental cancer drug cabozantinib showed promise in patients with a form of metastatic kidney cancer, according to a preliminary report from an early-stage trial. What's more, 19 of 21 patients in the trial showed tumor regression ...
 

Beyond the Abstract - Atypical presentations and rare metastatic sites of ...

UroToday
At present it is estimated that about 20-30% of patients have metastatic disease at diagnosis while another 20% will present with distant recurrence after radical nephrectomy. Given the dismal prognosis of metastatic renal cancer, reducing the risk of ...
 

Cabozantinib Shows Encouraging Activity In Pretreated Patients With Advanced RCC

NASDAQ
(RTTNews.com) - Exelixis, Inc. (EXEL) reported preliminary data from a cohort of heavily pretreated patients with metastatic refractory renal cell carcinoma, or RCC, participating in an ongoing phase 1b trial of cabozantinib.
 

Results Support Planned, Randomized Phase 3 ADAPT Study-

MarketWatch (press release)
... announced that updated results from an open label Phase 2 study of its Arcelis(TM) immunotherapy, AGS-003, in combination with sunitinib in patients with unfavorable risk, metastatic renal cell carcinoma (mRCC), had demonstrated prolonged survival.
 

New Oral Kinase Inhibitor Axitinib Approved for Advanced Renal Cancer

Pharmacy Practice News
?This is the seventh drug that has been approved for the treatment of metastatic or advanced kidney cell cancer since 2005,? Richard Pazdur, MD, director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and ...
 

Rare Benign Tumor Responds to Cancer Drug

MedPage Today
SAN FRANCISCO -- The cancer drug everolimus (Afinitor) appears to shrink a rare type of benign kidney tumor often seen with tuberous sclerosis, researchers found. Daily oral treatment shrank 42% of angiomyolipomas to at least half their original volume ...
 

Types of Cancer


Adrenal Cancer Anal Cancer Brain Cancer Colorectal Cancer Endometrial Cancer Esophageal Cancer
Esophageal Cancer Laryngeal Cancer Oral Cancer Penile Cancer Prostatic Cancer Stomach Cancer
Thyroid Cancer Bladder Cancer Bone Cancer Cervix Cancer Heart Cancer Kidney Cancer
Melanoma Cancer Pancreas Cancer Asbestos Cancer